Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Noble Acquires Property with Significant Uranium, Rare Earth, Phosphorus & Silver Mineralization (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Senseonics Holdings Inc SENS

Healthcare Medical Devices
Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The... see more

Recent & Breaking News (NYSEAM:SENS)

Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting

GlobeNewswire 8 days ago

Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch

GlobeNewswire December 9, 2024

Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences

GlobeNewswire November 12, 2024

Senseonics Holdings, Inc. Reports Third Quarter 2024 Financial Results

GlobeNewswire November 7, 2024

Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering

GlobeNewswire October 25, 2024

Senseonics Holdings, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for November 7, 2024 at 4:30 P.M. Eastern Time

GlobeNewswire October 24, 2024

Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System

GlobeNewswire October 16, 2024

Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor

GlobeNewswire October 10, 2024

Eversense 365 Receives FDA Clearance: The World's First One Year CGM

GlobeNewswire September 17, 2024

Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire September 6, 2024

Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results

Business Wire August 8, 2024

Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time

Business Wire July 25, 2024

Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook

Business Wire June 21, 2024

Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association's 84th Scientific Sessions

Business Wire June 13, 2024

Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference

Business Wire May 29, 2024

Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results

Business Wire May 13, 2024

Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management

Business Wire May 13, 2024

Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution

Business Wire May 9, 2024

Senseonics Holdings, Inc. to Participate in Upcoming Conferences

Business Wire May 2, 2024

Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time

Business Wire April 30, 2024